$WALD

Waldencast plc (WALD): Financial results for H1 2026

Waldencast plc (WALD) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Waldencast plc Announces First Half 2026 Financial Results September 28, 2026 – New York, New York – Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), the parent company of Milk Makeup, the clean prestige beauty brand born from the creative community of

Original reporting
Published Sep 28, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 8:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$WALD
Bearish
medium confidence
Mentioned
$WALD
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$WALDBearishLow
01

Why it matters

The earnings release signals a steep decline in operating performance, prompting likely short‑term price weakness.

02

Market read

Primary earnings disclosure for a small‑cap listed company; relevant for traders monitoring niche consumer‑goods stocks.

03

What to watch

Potential upside from the upcoming Milk Makeup product relaunch and reduced overhead costs.

Relevance 7/10Novelty 8/10Timing: post‑market release

Background

Waldencast plc (NASDAQ: WALD) is a beauty company owning Milk Makeup, recently divested its Obagi Medical business.

Company-level read

Ticker impact

$WALDBearishMedium confidence
Context

Waldencast disclosed H1 2026 results with net revenue down 57% YoY and a net loss of $94.9 million, plus the sale of Obagi Medical for $149.9 million.

Expected impact

downward pressure as investors price in weaker performance and debt repayment.

Evidence & confidence

The sharp revenue drop and loss, combined with a delisting plan, suggest reduced investor confidence.

Market effects

Highlights challenges in the prestige beauty segment and may affect peers with similar exposure.

Limited to U.S. and UK investors; no broader market effect.

Minimal global impact beyond niche beauty investors.

Counterpoint

The cash proceeds and debt repayment could enable a turnaround if the brand execution improves.

Key entities

  • Waldencast plc

    Parent company of Milk Makeup, listed on NASDAQ.

  • Bridgepoint

    Acquired Obagi Medical from Waldencast.

Related articles

$WALDHighAI 8/10

Why is Waldencast stock sliding today?

Waldencast stock fell 15.3% after announcing plans to delist from Nasdaq by October 2, 2026, and seek OTC quotation under the new ticker 'MLKM'. The company cited high U.S. listing costs and reduced need for public equity markets. The Nasdaq Composite and S&P 500 also declined, amplifying the selling pressure. The move is seen as a liquidity downgrade, potentially triggering forced selling by institutional funds.

$ACNMed

What Are Accenture Stock Bears Missing?

Accenture (ACN) reports 100 new AI projects in Q3 2026, with AI partner bookings on track to double. Despite a 24% stock decline over the past year, shares rose 38% in the last three months. Revenue growth has been slow, with consulting revenue up just 1% in Q3. The company expects fiscal 2026 revenue growth of 3%-4%. ACN trades at a lower multiple than the S&P 500, reflecting slower growth expectations.

$MTNMed

Vail Resorts (MTN) Reports Steep Net Income Drop Amid Dividend S

Vail Resorts (MTN) reported a 47.5% drop in net income and a wider loss per share for FY26, despite a 2.6% revenue increase to $278.1M. The company projects FY27 net income between $158M-$233M and resort EBITDA between $805M-$865M. MTN offers a 6.47% dividend yield, but its payout ratio is 171%, raising sustainability concerns. The stock is modestly undervalued with a GF Value of $182.41 vs. the current price of $138.09. Insider activity and guru holdings signal confidence.